Mon, Jun 18, 2018
Shares of Vedanta and Dr Reddy's Labs fell up to 4 per cent after the 30 shares on benchmark Sensex got reshuffled with some exlusion and inclusion with effect from Monday. Under the reconstitution, Vedanta entered the benchmark index, while Dr Reddy's Labs exited the index.
More >
Fri, Nov 04, 2016
Indian shares fell to their lowest in nearly four months on Friday, led by drug makers, after Bloomberg reported that US prosecutors could file charges by year-end in a criminal investigation of generic makers over suspected price collusion.
Tue, Oct 25, 2016
Dr Reddy's Laboratories today reported a decline of 60.12 per cent in consolidated net profit for the September quarter at Rs 308.9 crore, mainly because of drop in sales in Venezuela and North America.
Wed, Aug 31, 2016
Following the FDC ban, this market fell by 3.9% to Rs 234 crore in the given quarter. Whereas drugs under NLEM grew by 1.6% to Rs 1061 crore, while non-NLEM drugs posted growth of 11.2% to Rs 7677 crore.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
